...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Biogen/Eisai Scrap Aducanumab

Other stocks with "plaque related" therapies are declining by association with Biogen.  RVX' approach to dementia is different enough that there could be a benefit.  I wonder if the company will try to point this out.

Share
New Message
Please login to post a reply